ENGN Latest Headlines

3 Best Stocks to Buy Today, 1/30/2026, According to Top Analysts

at www.tipranks.com (Fri, 30-Jan 8:23 AM)

enGene’s $130 Million Offering Highlights Investor Confidence in Genetic Medicine Platform

Market Chameleon (Thu, 13-Nov 8:25 AM)

enGene Schedules Conference Call for Key LEGEND Trial Update—Spotlight on Non-Viral Gene Therapy Advances

Market Chameleon (Tue, 11-Nov 10:28 AM)

ENGN's Detalimogene Delivers Improved 6-Month Complete Response Rate and Exceeds Enrollment Targets in Key Bladder Cancer Trial

Market Chameleon (Tue, 11-Nov 9:09 AM)